U.S. Health Care REITs Stock News

Stock performance snapshot and context Marriott Vacations Worldwide (VAC) has drawn investor attention after a strong run in the stock, with gains over the past month and past 3 months prompting closer inspection of the company’s fundamentals and recent performance trends. See our latest analysis for Marriott Vacations Worldwide. That recent surge sits on top of a much longer rebuild in sentiment, with a 58.67% year to date share price return contrasting with a 45.12% total shareholder return...

AbCellera Biologics (ABCL) has drawn investor attention after appointing Victor Sandor, M.D.C.M, as an independent director. He brings drug development and regulatory approval experience from roles at Array BioPharma, Incyte, Biogen and AstraZeneca. See our latest analysis for AbCellera Biologics. The appointment of Victor Sandor comes as AbCellera’s share price has climbed 47.61% over the past 90 days and 52.77% year to date. The 1-year total shareholder return of 65.82% contrasts with a...

In recent months, Take-Two Interactive Software insiders, including Executive Chairman & CEO Strauss Zelnick, have sold large blocks of shares, while analysts and investors have focused on the company’s upcoming Grand Theft Auto VI release and its recent earnings beat. At the same time, investors are increasingly interested in Take-Two’s shift toward a platform-style model built around recurring spending, subscriptions, and persistent game worlds rather than one-off title launches. We’ll now...

Why AZZ stock is drawing attention now AZZ (AZZ) is back on investors’ radar after recent trading saw the stock move while key return figures stand out, putting its metal coatings and coil coating business in sharper focus. See our latest analysis for AZZ. Recent trading has been strong, with the latest share price at $150.89, a 90 day share price return of 21.9% and a 1 year total shareholder return of 68.75%, pointing to building momentum on both shorter and longer horizons. If AZZ’s run...

In early June 2026, GameStop reported first-quarter sales of US$835.3 million and net income of US$389.6 million, while unveiling a new US$2.00 billion share repurchase program running through 2029. At the same time, CEO Ryan Cohen launched a hostile takeover bid for eBay, signaling an effort to recast GameStop as a broader e-commerce and collectibles platform rather than a traditional bricks-and-mortar gaming retailer. We’ll now examine how GameStop’s aggressive US$2.00 billion buyback plan...

Bread Financial Holdings recently presented at the Morgan Stanley US Financials Conference in New York, where Executive VP & CFO Perry S. Beberman highlighted the company’s improving credit trends, including lower net principal losses and easing delinquencies. Analysts are increasingly focusing on how these better credit metrics, together with a run of positive earnings surprises and capital return activity, may be reshaping assessments of Bread Financial’s earnings power and risk...

Earlier in June 2026, Travere Therapeutics reported long-term Phase 3 DUPLEX open-label extension data showing durable proteinuria reductions and up to five years of tolerability for FILSPARI in focal segmental glomerulosclerosis, alongside its first non-GAAP profitable quarter driven by the drug’s commercial performance. This combination of sustained clinical benefit in a rare kidney disease and an early move into profitability highlights how central FILSPARI has become to Travere’s...

The sudden progress toward a US Iran peace deal and the potential reopening of the Strait of Hormuz has pulled oil prices lower and shifted attention to companies that are sensitive to fuel costs and global stability. For investors, this is a moment to reassess which stocks might benefit if cheaper energy and reduced geopolitical risk persist, and which could lose some pricing power. This article highlights 3 stocks from a Global Airlines and Travel screener that appear positively exposed to...

Franklin Resources (BEN) has drawn fresh attention after presenting at the Morgan Stanley US Financials Conference 2026, shortly after the launch of its Franklin BSP CLO ETF and a new partnership focused on tokenized fund access. See our latest analysis for Franklin Resources. Those launches and partnerships have arrived during a strong run for the stock, with the 90 day share price return of 30.5% helping lift the year to date share price return to 35.0%, while the 1 year total shareholder...

On June 10, 2026, Tecnoglass Inc. announced it will pay a quarterly cash dividend of US$0.15 per share for the second quarter of 2026, scheduled for July 31, 2026 to shareholders of record as of June 30, 2026. This dividend update, alongside a US$1.36 billion project backlog, signals that Tecnoglass is emphasizing both ongoing business momentum and direct cash returns to shareholders. Next, we’ll examine how Tecnoglass’s US$0.15 quarterly dividend and project backlog strength influence its...

Devon Energy stock overview Devon Energy (DVN) stock has attracted attention after recent price moves, with the share closing at US$45.31. For investors, a key question is how this level aligns with the company’s current fundamentals. See our latest analysis for Devon Energy. Recent trading reflects a mixed picture, with the 1-day share price return of 1.57% and year-to-date share price return of 19.65% contrasting with a 1-month share price return that is down 8.45%. The 1-year total...

The Defiance 2X Space ETF (SPCL) repositioned around SpaceX before its debut and gained 56% before the ETF entered a trading halt.

Recent performance puts Cleveland-Cliffs stock in focus Cleveland-Cliffs (CLF) has drawn fresh attention after a strong run in its stock, with the price up 0.5% over the past day, 8.7% over the past week and 65% over the past 3 months. See our latest analysis for Cleveland-Cliffs. The recent 33.7% 1 month share price return and 65% 3 month share price return stand in contrast to a 1 year total shareholder return of 88.5%, but a 5 year total shareholder return that is down 34%. This suggests...

In recent days, PagSeguro Digital has drawn increased attention as analysts highlighted its five-year track record of rising revenue and operating profit, along with the expansion of its PagBank digital banking platform despite Brazil’s challenging macroeconomic backdrop. What stands out is that some analysts now view PagSeguro as undervalued relative to its earnings power, arguing that the market may be underappreciating both its diversified fintech model and its resilience in a volatile...

Constellium (CSTM) is back in focus after its Q1 2026 earnings, where higher revenue and profitability, plus a sharply raised full year earnings estimate, contrast with heavy insider selling and fresh valuation worries. See our latest analysis for Constellium. The recent Q1 2026 update comes after a strong run in the stock, with an 80.07% year to date share price return and a very large 164.68% one year total shareholder return, indicating powerful but increasingly debated momentum. If you...

Kratos Defense & Security Solutions (KTOS) is back in focus after J.P. Morgan shifted its rating to Overweight, highlighting growth prospects in hypersonics, tactical drones, turbojet engines, and space surveillance work. See our latest analysis for Kratos Defense & Security Solutions. At a share price of US$57.75, Kratos has recently given up some ground in the short term, with the 7 day share price return slightly negative, but the 1 month share price return up 10.87% and the year to date...

Earlier this month, Genesis Energy, L.P. presented at Bank of America’s Energy & Power Credit Conference and RBC Capital Markets’ Global Energy, Power & Infrastructure Conference in New York, highlighting its Gulf of Mexico offshore pipeline network and recent balance sheet improvements. The company’s combination of reduced debt maturities, lower interest burden, and ramping Shenandoah and Salamanca projects underscores a business increasingly anchored by long-term, tariff-based cash...

Why Ingredion (INGR) is on investors’ radar today Ingredion (INGR) has drawn attention after recent trading left the stock down over the past month and past 3 months, prompting investors to recheck the valuation against its fundamentals and business mix. See our latest analysis for Ingredion. At a share price of US$101.59, Ingredion has seen its short term share price momentum fade, with the 90 day share price return down 10.18% and the 1 year total shareholder return down 24.15%, despite...

Earlier this month, Personalis announced clinical data from the 2026 ASCO meeting showing its NeXT Personal assay can detect minimal residual disease at ultra-low levels across six solid tumor types, with strong correlations to relapse and progression risk in colorectal, lung, ovarian, endometrial, melanoma, and renal cancers. Shortly afterward, the company received CE Mark Class A approval for its EDTA and cfDNA Blood Collection Kits, opening the door for broader use of its MRD ecosystem in...

Digi International (DGII) has put its cloud-based Digi Axess platform in the spotlight, rolling out seven new features that tighten remote access, centralize SIM oversight, and broaden data visualization for industrial customers. See our latest analysis for Digi International. Those Digi Axess upgrades arrive as momentum in the stock has been strong, with a 36.76% 3 month share price return and a 59.13% year to date share price return, contributing to a 106.18% 1 year total shareholder...

In recent days, Alpha Metallurgical Resources benefited from a sector-wide upswing in coking coal producers, as improving sentiment toward metallurgical coal lifted the company alongside peers such as Warrior Met Coal and Ramaco Resources. At the same time, insider purchases totaling about US$4.40 million and indications that the shares may be trading above intrinsic value add an interesting contrast between internal confidence and external valuation assessments. We’ll now examine how this...

Moderna recently presented at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 in Miami, highlighting progress across its mRNA vaccine and oncology pipeline, including regulatory filings for its influenza vaccine and advances in its personalized cancer vaccine program with Merck. This combination of late-stage cancer vaccine data, broader infectious disease ambitions, and ongoing patent disputes with BioNTech is reshaping how investors assess the durability and breadth of...

Earlier this month, Lightwave Logic, Inc. filed an omnibus shelf registration that covers potential future issuances of common stock, preferred stock, warrants, and units. This broad financing framework gives the company flexibility to raise capital through multiple instruments over time, which can influence investor expectations about funding plans and balance-sheet strength. Next, we’ll examine how this new omnibus shelf registration could shape Lightwave Logic’s investment narrative and...

DiamondRock Hospitality (DRH) has drawn fresh attention after recent trading, with the stock last closing at $11.92. For investors, the focus now is on how this hotel focused REIT’s fundamentals line up with its recent momentum. See our latest analysis for DiamondRock Hospitality. The recent 1 month share price return of 15.73% and 90 day share price return of 25.34%, alongside a 1 year total shareholder return of 63.53%, point to building momentum around DiamondRock Hospitality as investors...